The hallucinogenic world of tryptamines: an updated review

被引:72
作者
Araujo, Ana Margarida [1 ]
Carvalho, Felix [1 ]
Bastos, Maria de Lourdes [1 ]
de Pinho, Paula Guedes [1 ]
Carvalho, Marcia [1 ,2 ]
机构
[1] Univ Porto, Fac Farm, Dept Ciencias Biol, UCIBIO REQUIMTE,Lab Toxicol, P-4050313 Oporto, Portugal
[2] Fundacao Ensino & Cultura Fernando Pessoa, CEBIMED, FP ENAS, Oporto, Portugal
关键词
Tryptamines; Hallucinogens; 5-HT2A receptor; Toxicokinetics; Toxicodynamics; Toxicity; LYSERGIC-ACID DIETHYLAMIDE; DISCRIMINATIVE STIMULUS PROPERTIES; TETRAHYDRO-BETA-CARBOLINES; HUMAN LIVER-MICROSOMES; PROPOSED ANIMAL-MODEL; HUMAN URINE SPECIMENS; IN-VIVO METABOLISM; O-H-LSD; MONOAMINE-OXIDASE; DIMETHYLTRYPTAMINE DMT;
D O I
10.1007/s00204-015-1513-x
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
In the area of psychotropic drugs, tryptamines are known to be a broad class of classical or serotonergic hallucinogens. These drugs are capable of producing profound changes in sensory perception, mood and thought in humans and act primarily as agonists of the 5-HT2A receptor. Well-known tryptamines such as psilocybin contained in Aztec sacred mushrooms and N,N-dimethyltryptamine (DMT), present in South American psychoactive beverage ayahuasca, have been restrictedly used since ancient times in sociocultural and ritual contexts. However, with the discovery of hallucinogenic properties of lysergic acid diethylamide (LSD) in mid-1900s, tryptamines began to be used recreationally among young people. More recently, new synthetically produced tryptamine hallucinogens, such as alpha-methyltryptamine (AMT), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), emerged in the recreational drug market, which have been claimed as the next-generation designer drugs to replace LSD ('legal' alternatives to LSD). Tryptamine derivatives are widely accessible over the Internet through companies selling them as 'research chemicals', but can also be sold in 'headshops' and street dealers. Reports of intoxication and deaths related to the use of new tryptamines have been described over the last years, raising international concern over tryptamines. However, the lack of literature pertaining to pharmacological and toxicological properties of new tryptamine hallucinogens hampers the assessment of their actual potential harm to general public health. This review provides a comprehensive update on tryptamine hallucinogens, concerning their historical background, prevalence, patterns of use and legal status, chemistry, toxicokinetics, toxicodynamics and their physiological and toxicological effects on animals and humans.
引用
收藏
页码:1151 / 1173
页数:23
相关论文
共 197 条
[1]   EFFECTS OF DOM AND DMT IN A PROPOSED ANIMAL-MODEL OF HALLUCINOGENIC ACTIVITY [J].
ADAMS, LM ;
GEYER, MA .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1985, 9 (02) :121-132
[2]   A PROPOSED ANIMAL-MODEL FOR HALLUCINOGENS BASED ON LSDS EFFECTS ON PATTERNS OF EXPLORATION IN RATS [J].
ADAMS, LM ;
GEYER, MA .
BEHAVIORAL NEUROSCIENCE, 1985, 99 (05) :881-900
[3]   Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative [J].
Alatrash, G ;
Majhail, NS ;
Pile, JC .
MAYO CLINIC PROCEEDINGS, 2006, 81 (04) :550-551
[4]  
ANDEN NE, 1968, BRIT J PHARMACOL, V34, P1
[5]  
[Anonymous], MAPS B
[6]  
[Anonymous], 2012, Euro. Surveill, DOI DOI 10.2810/64775
[7]   INVOLVEMENT OF 5-HT RECEPTOR SUBTYPES IN THE DISCRIMINATIVE STIMULUS PROPERTIES OF MESCALINE [J].
APPEL, JB ;
CALLAHAN, PM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 159 (01) :41-46
[8]   Piperazine compounds as drugs of abuse [J].
Arbo, M. D. ;
Bastos, M. L. ;
Carmo, H. F. .
DRUG AND ALCOHOL DEPENDENCE, 2012, 122 (03) :174-185
[9]   Natural product 'legal highs' [J].
Arunotayanun, Warunya ;
Gibbons, Simon .
NATURAL PRODUCT REPORTS, 2012, 29 (11) :1304-1316
[10]   Emerging Drugs of Abuse [J].
Babu, Kavita ;
Boyer, Edward W. ;
Hernon, Christina ;
Brush, D. Eric .
CLINICAL PEDIATRIC EMERGENCY MEDICINE, 2005, 6 (02) :81-84